导师风采
王笑民
浏览量:511   转发量:5

个人信息

Personal Information

  • 主任医师
  • 导师类别:博士生导师
  • 性别: 男
  • 学历:博士研究生
  • 学位:博士

联系方式

Contact Information

  • 所属院系:附属北京中医医院
  • 所属专业: 中医内科学
  • 邮箱 : wangxiaomin_bhtcm@126.com
  • 工作电话 : -

个人简介

Personal Profile

        王笑民,教授、主任医师、博士生导师,现任中国中西医结合学会肿瘤专业委员会主任委员,北京中医药学会肿瘤专业委员会名誉主委,中华中医药学会肿瘤分会副主任委员,北京抗癌协会第八届理事会常务理事等。

        长期致力于益气活血法抗肿瘤的研究,率先提出“益气活血法治疗肿瘤”的新观点,相关研究成果曾6次获得不同级别的科技成果奖励。先后承担国家“八五”、“九五”攻关课题、国家自然科学基金项目和北京市科委重大项目等多项科研项目。发表学术论文百余篇,其中SCI收录20余篇。参与编写专业论著10余部。先后被评为"北京科技之星"、"全国中西医结合优秀中青年科技工作者"、"北京市卫生系统先进个人"、"新世纪百千万人才工程北京市级人选"等。其参与研究的《榄香烯脂质体系列靶向抗癌天然药物产业化技术及其应用》项目荣获国家科技进步二等奖。2015年获得中华人民共和国国务院政府特殊津贴。


  • 研究方向Research Directions
中西医结合肿瘤
2. 机电结构优化与控制 研究内容:在对机电结构进行分析和优化的基础上,运用控制理论进行结构参数的调整,使结构性能满足设计要求。1. 仿生结构材料拓扑优化设计, 仿生机械设计 研究内容:以仿生结构为研究对象,运用连续体结构拓扑优化设计理论和方法,对多相仿生结构(机构)材料进行2. 机电结构优化与控制 研究内容:在对机电结构进行分析和优化的基础上,运用控制理论进行结构参数的调整,使结构性能满足设计要求。1. 仿生结构材料拓扑优化设计, 仿生机械设计 研究内容:以仿生结构为研究对象,运用连续体结构拓扑优化设计理论和方法,对多相仿生结构(机构)材料进行整体布局设计。 整体布局设计。
团队展示

       拥有一批高水平的学术团队,在职人员35名,研究生以上学历占90%,其中博士生导师3名,硕士生导师4名。


     


     

       

        提出“团队带团队”的新名医培养模式,加速了一专多能的中医人才培养,引起了国家中医管理局领导的高度关注。完成首都医科大学中西医结合肿瘤学研究生教材1部,承担首医研究生课程1项,承担教学课题一项。参编国家十一五规划教材《中医肿瘤学》。作为学科带头人带领肿瘤科成功申报成为国家卫计委重点专科、国家中医管理局重点专科、国家中医管理局重点学科、北京中西医结合肿瘤重点学科和北京中医肿瘤重点专科。



项目情况

1: 基于肝素酶对化疗性外泌体摄入的ARF6/PIPK/PIP2/syndecan通路影响探讨固本抑瘤II号干预三阴性乳腺癌化疗抵抗 的作用机制-国家自然科学基金(202101-202412)1,55.00万元,本人可支配55.00万元

 2: 基于乏氧HS-VEGF-VM探讨固本抑瘤II号干预三阴性乳腺癌机制-北京市自然科学基金(202001-202212)1,20.00万元, 本人可支配20.00万元


研究成果

重要英文学术论文

[1] Clinical characteristics and prognostic analysis of Lung Cancer patients with Hypercoagulability: A single-center, retrospective, real-world study. Journal of Cancer. 2021,12(10):2968–2974. Yunfei Ma, Guangda Li,Xiaoxiao Li, Yu Gao, Tongjing Ding, Guowang Yang, Yi Zhang, Jiayun Nian, Mingwei Yu,* and Xiaomin Wang*SCI(IF=4.207)

[2] Comparative efficacy and safety of metronomic chemotherapy in breast cancer. Medicine.2021,100(23):e26255. Ying Xie, Xinjie Chen, Bingxue Li, and Xiaoming Wang* SCI(IF=1.889) 

[3] Effects of Acupuncture and Moxibustion on Breast Cancer-Related Lymphedema: A Systematic Review andMeta-Analysis of Randomized Controlled Trials. Integrative Cancer Therapies. 2021,20:15347354211044107. YuGao, Tingting Ma, Mei Han, Mingwei Yu, Xiuhui Wang, Yiren Lv, Xiaomin Wang* SCI(IF=3.279) 

[4] Poultry and Fish Intake and Pancreatic Cancer Risk: a Systematic Review and Meta-analysis. Nutr Cancer.2021,2021:1-13. Yu Gao, Yunfei Ma, Mingwei Yu, Guangda Li, Yuhan Chen, Xiaoxiao Li, Xinjie Chen, Ying Xie,Xiaomin Wang* SCI(IF=2.363) 

[5] Efficacy of acupuncture in the prevention and treatment of chemotherapy-induced nausea and vomiting inpatients with advanced cancer: a multi-center, single-blind, randomized, sham-controlled clinical research.Chinese Medicine. 2020,15(1):57. Qi-Wei Li, Ming-Wei Yu*, Xiao-Min Wang*, Guo-Wang Yang, Huan Wang,Chen-Xi Zhang, Na Xue, Wei-Ru Xu, Yi Zhang, Pei-Yu Cheng, Lin Yang, Qi Fu, Zhong Yang SCI(IF=5.455) 

[6] Prevention for chemotherapy-induced nausea and vomiting with acupuncture:a systematic review protocol.Medicine. 2020,99(3):e18828. Ting-Ting Ma, Tao Zhang, Gan-Lin Zhang, Cun-Fang Dai, Bo-Ran Zhang, XiaoMin Wang*, Lin-Peng Wang SCI(IF=1.552) 

[7] Efficacy of acupuncture in the prevention and treatment of chemotherapy-induced nausea and vomiting inpatients with advanced cancer: a multi-center, single-blind, randomized, sham-controlled clinical research.Chinese Medicine. 2020,15:57. Qi-Wei Li, Ming-Wei Yu, Xiao-Min Wang*, Guo-Wang Yang, Huan Wang, Chen-Xi Zhang, Na Xue, Wei-Ru Xu, Yi Zhang, Pei-Yu Cheng, Lin Yang, Qi Fu, Zhong Yang SCI(IF=2.96) 

[8] Scutellaria barbata and Hedyotis diffusa herb pair for breast cancer treatment: Potential mechanism basedon network pharmacology. J Ethnopharmacol . . 2020,259:112929. Ting-Ting Ma, Gan-Lin Zhang, Cun-FangDai, Bo-Ran Zhang, Ke-Xin Cao, Chun-Guo Wang, Guo-Wang Yang, Xiao-Min Wang* SCI(IF=3.69) 

[9] SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis viamodulating autophagy in heparanase overexpressed triple-negative breast cancer. J Ethnopharmacol.2020,266:113400. Qi-Wei Li, Gan-Lin Zhang, Cai-Xia Hao, Yun-Fei Ma, Xu Sun, Yi Zhang, Ke-Xin Cao, Bing-XueLi, Guo-Wang Yang, Xiao-Min Wang* SCI(IF=3.69) 

[10] Significance of host heparanase in promoting tumor growth and metastasis. Matrix Biol. 2020,93:25-42.Gan-Lin Zhang, Lilach Gutter-Kapon, Neta Ilan, Tahira Batool, Kailash Singh, Andreas Digre, Zhengkang Luo,Stellan Sandler, Yuval Shaked, Ralph D Sanderson, Xiao-Min Wang*, Jin-Ping Li, Israel Vlodavsky SCI(IF=8.572) 

[11] Prognostic significance of thrombocytosis in lung cancer: a systematic review and meta-analysis. Platelets.2020,2020:1-9. Yunfei Ma, Guangda Li, Mingwei Yu, Xu Sun, Jiayun Nian, Yu Gao, Xiaoxiao Li, Tongjing Ding,Xiaomin Wang* SCI(IF=3.378) 

[12] The Effect of Ginkgo Biloba Dropping Pills on Hemorheology and Blood Lipid: A Systematic Review ofRandomized Trials. Evid Based Complement Alternat Med. 2019,2019:1-12. Hong Chen,Cihang Zhou,MingweiYu,Shuo Feng,Yunfei Ma,Zhengrong Liu,Jiahui Zhang,Tongjing Ding,Bo Li, Xiaomin Wang* SCI(IF=1.984) [13] Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad. Journal of VisualizedExperiments. 2019,143: e58604. Gan-Lin Zhang,Yi Zhang,Ke-Xin Cao, Xiao-Min Wang* SCI(IF=1.108) 

[14] Establishment of a murine breast tumor model by subcutaneous or orthotopic implantation. OncologyLetters. 2018,15(5):6233–6240. YI ZHANG, GAN-LIN ZHANG, XU SUN, KE-XIN CAO, CONG MA, NAN NAN,GUO-WANG YANG, MING-WEI YU and XIAO-MIN WANG* SCI(IF=1.39) 

[15] Anti-cancer effects of fisetin on mammary carcinoma cells via regulation of the PI3K/Akt/mTOR pathway:In vitro and in vivo studies. Int J Mol Med. 2018,242(2):811–820. Xu Sun, Xueman Ma, Qiwei Li, et alSCI(IF=2.34) 

[16] Establishment of a murine breast tumor model by subcutaneous or orthotopic implantation. oncologyletters. 2018,15:6233-6240. Zhang, Y.; Zhang, G.L.*; Sun, X.; Cao, K.X.; Ma, C.; Nan, N.; Yang, G.W.; Yu, M.W.;Wang, X.M.* SCI(IF=1.39) 

[17] Effects of the Chinese Medicine Yi Shen Jian Gu Granules On Aromatase Inhibitor-AssociatedMusculoskeletal Symptoms: A Randomized, Controlled Clinical Trial. breast. 2018, 37:18-27. Nan Peng,Mingwei Yu, Guowang Yang, Qi Fu, Yongmei Xu, Jie Yu, Qiang Liu, Chen Li, Weiru Xu, Yi Zhang, Cong Ma, LinYang, Rencun Yu and Xiaomin Wang* SCI(IF=2.801) 

[18] Effects of the Chinese Medicine Yi Shen Jian Gu Granules On Aromatase Inhibitor-AssociatedMusculoskeletal Symptoms: A Randomized, Controlled Clinical Trial. breast. 2018,37:18-27. Nan Peng, MingweiYu, Guowang Yang, Qi Fu, Yongmei Xu, Jie Yu, Qiang Liu, Chen Li, Weiru Xu, Yi Zhang, Cong Ma, Lin Yang,Rencun Yu and Xiaomin Wang* SCI(IF=2.801) 

[19] Identification of regulatory role of DNA methylation in colon cancer gene expression via systematicbioinformatics analysis. Medicine. 2017,96:47. Yong Yang, Fuhao Chu, Weiru Xu, Jiaqi Sun, Xu Sun, Xueman Ma,Mingwei Yu, Guowang Yang, Xiaomin Wang* SCI(IF=1.804) 

[20] Treatment of Triple-Negative Breast Cancer with Chinese Herbal Medicine: A Prospective Cohort StudyProtocol. . Medicine (Baltimore). 2017,96(44):e8408. Hui Meng, Nan Peng, Mingwei Yu, Xu Sun, Yunfei Ma,Guowang Yang and Xiaomin Wang* SCI(IF=1.804) 

[21] The Platelet-To-Lymphocyte Ratio as a Predictor of Patient Outcomes in Ovarian Cancer: A Meta-Analysis.Climacteric. 2017, 20(5):448-455. Xueman Ma, Xu Sun, Guowang Yang, Mingwei Yu, Ganlin Zhang, Jie Yu, YiZhang and Xiaomin Wang* SCI(IF=2.271) 

[22] Gubenyiliu II Inhibits Breast Tumor Growth and Metastasis Associated with Decreased HeparanaseExpression and Phosphorylation of ERK and AKT Pathways. Molecules. 2017,787(22):1-17. Yi Zhang,GanlinZhang,Xu Sun,Kexin Cao,Yawen Shang,Muxin Gong,Cong Ma,Nan Nan,Jinping Li,Mingwei Yu,GuowangYang,Xiaomin Wang* SCI(IF=2.465) 

[23] Diagnostic Accuracy of Methylated SEPT9 for Blood-based Colorectal Cancer Detection: A SystematicReview and Meta-Analysis. Clinical and Translational Gastroenterology. 2017,2017:1-10. Jiayun Nian, Xu Sun,Su Yang Ming, Chen Yan, Yunfei Ma, Ying Feng, Lin Yang, Mingwei Yu, Ganlin Zhang, Xiaomin Wang*SCI(IF=3.472)

重要奖项

2012年王笑民医师作为第五完成人荣获国家科技进步二等奖

2009年王笑民作为第九完成人荣获教育部科学技术进步奖一等奖

2009年王笑民作为第六完成人荣获中国中西医结合学会科学技术一等奖

2000年王笑民作为第三完成人荣获北京市人民政府颁发的北京市科技进步三等奖

1997年王笑民作为第二完成人荣获北京市科技进步三等奖

1996年荣获北京市中医管理局科技成果二等奖

1995年荣获北京市中医管理局科技成果二等奖

1994年荣获北京市中医管理局科技成果二等奖

1993年王笑民作为第四完成人荣获北京市科技进步三等奖:

1991年荣获北京市中医管理局科技成果二等奖


学生信息
当前位置:教师主页 > 学生信息
入学日期
所学专业
学号
学位
招生信息
当前位置:教师主页 > 招生信息
招生学院
招生专业
研究方向
招生人数
推免人数
考试方式
招生类别
招生年份

首都医科大学研究生院招生办公室

360eol提供技术支持

Copyright © 2011 -All Rights Reserved 苏ICP备08015343号-4

文件上传中...

分享
回到
首页
回到
顶部